PARNAX LAB Financial Statement Analysis
|
||
|
The Revenues of PARNAX LAB have decreased by -98.97% YoY .
The Earnings Per Share (EPS) of PARNAX LAB has increased by 11.60 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PARNAX LAB Last 5 Annual Financial Results
[BOM: 506128]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹168 Cr | ₹16,303 Cr | ₹90 Cr | ₹95 Cr | ₹109 Cr |
| Expenses | ₹145 Cr | ₹14,000 Cr | ₹80 Cr | ₹89 Cr | ₹99 Cr |
| Operating Profit (Excl OI) | ₹23 Cr | ₹2,303 Cr | ₹9.95 Cr | ₹6.43 Cr | ₹10 Cr |
| Other Income | ₹0.77 Cr | ₹33 Cr | ₹0.21 Cr | ₹0.67 Cr | ₹2.11 Cr |
| Interest | ₹4.95 Cr | ₹523 Cr | ₹5.08 Cr | ₹4.60 Cr | ₹3.89 Cr |
| Depreciation | ₹6.53 Cr | ₹587 Cr | ₹5.16 Cr | ₹4.46 Cr | ₹3.82 Cr |
| Profit Before Tax | ₹12 Cr | ₹1,226 Cr | ₹-0.08 Cr | ₹-1.97 Cr | ₹4.62 Cr |
| Profit After Tax | ₹8.63 Cr | ₹826 Cr | ₹-0.36 Cr | ₹-2.92 Cr | ₹3.31 Cr |
| Consolidated Net Profit | ₹8.62 Cr | ₹824 Cr | ₹-0.36 Cr | ₹-2.91 Cr | ₹3.30 Cr |
| Earnings Per Share (Rs) | ₹8.37 | ₹7.50 | ₹8.40 | ₹-0.43 | ₹-3.43 |
| PAT Margin (%) | 5.10 | 5.15 | 5.07 | -0.40 | -3.06 |
| ROE(%) | 14.39 | 15.91 | 20.93 | -1.11 | -8.51 |
| ROCE(%) | 13.61 | 15.20 | 17.34 | 5.83 | 3.27 |
| Total Debt/Equity(x) | 0.99 | 0.82 | 1.41 | 1.71 | 1.54 |
Key Financials |
||
| Market Cap | : | ₹ 204.2 Cr |
| Revenue (TTM) | : | ₹ 195.8 Cr |
| Net Profit(TTM) | : | ₹ 11.8 Cr |
| EPS (TTM) | : | ₹ 10.3 |
| P/E (TTM) | : | 17.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PARNAX LAB | 13.6% | -0.6% | 111% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
| CIPLA | -1.1% | -0.3% | 20.7% |
| DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
| ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
| DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
| MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
| TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
| LUPIN | 0.9% | 7.2% | 72.7% |
PARNAX LAB Revenues
[BOM: 506128]
| Y-o-Y | -98.97 % |
| 5 Yr CAGR | 11.41 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹168 Cr | -98.97 | |
| Mar2023 | ₹16,303 Cr | 18,002.56 | |
| Mar2022 | ₹90 Cr | -5.51 | |
| Mar2021 | ₹95 Cr | -12.38 | |
| Mar2020 | ₹109 Cr | - | |
PARNAX LAB Operating Profit
[BOM: 506128]
| Y-o-Y | -99.00 % |
| 5 Yr CAGR | 22.46 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹23 Cr | -99.00 | |
| Mar2023 | ₹2,303 Cr | 23,053.01 | |
| Mar2022 | ₹9.95 Cr | 54.77 | |
| Mar2021 | ₹6.43 Cr | -37.12 | |
| Mar2020 | ₹10 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -2.90 % |
| 5 Yr CAGR | 9.91 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 13.72% | -2.90 | |
| Mar2023 | 14.13% | 27.99 | |
| Mar2022 | 11.04% | 63.80 | |
| Mar2021 | 6.74% | -28.30 | |
| Mar2020 | 9.4% | - | |
PARNAX LAB Profit After Tax
[BOM: 506128]
| Y-o-Y | -98.95 % |
| 5 Yr CAGR | 27.13 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹8.62 Cr | -98.95 | |
| Mar2023 | ₹824 Cr | Positive | |
| Mar2022 | ₹-0.36 Cr | Negative | |
| Mar2021 | ₹-2.91 Cr | Negative | |
| Mar2020 | ₹3.30 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -0.97 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 5.1 % | -0.97 | |
| Mar2023 | 5.15 % | 1.58 | |
| Mar2022 | 5.07 % | Positive | |
| Mar2021 | -0.4 % | Negative | |
| Mar2020 | -3.06 % | - | |
PARNAX LAB Earnings Per Share (EPS)
[BOM: 506128]
| Y-o-Y | 11.60 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹8.37 | 11.60 | |
| Mar2023 | ₹7.50 | -10.71 | |
| Mar2022 | ₹8.40 | Positive | |
| Mar2021 | ₹-0.43 | Negative | |
| Mar2020 | ₹-3.43 | - | |
PARNAX LAB Return on Capital Employed (ROCE)
[BOM: 506128]
| Y-o-Y | -10.46 % |
| 5 Yr CAGR | 42.83 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 13.61% | -10.46 | |
| Mar2023 | 15.2% | -12.34 | |
| Mar2022 | 17.34% | 197.43 | |
| Mar2021 | 5.83% | 78.29 | |
| Mar2020 | 3.27% | - | |
PARNAX LAB Share Price vs Sensex
| Current Share Price | : | ₹177.6 |
| Current MarketCap | : | ₹ 204.2 Cr |
| Updated EOD on | : | Dec 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 13.6% |
-0.6% |
111% |
| SENSEX | -2.1% |
-2% |
11.3% |
PARNAX LAB related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about PARNAX LAB Financials
How the annual revenues of PARNAX LAB have changed ?
The Revenues of PARNAX LAB have decreased by -98.97% YoY .
How the Earnings per Share (EPS) of PARNAX LAB have changed?
The Earnings Per Share (EPS) of PARNAX LAB has increased by 11.60 % YoY .
Check out Intrinsic Value of Peers of PARNAX LAB
Compare Stock Analytics of Peers of PARNAX LAB
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
